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The computerization of method development and validation are useful in analysis of pharmaceuticals in 
pharmaceutical industry. In this article a simple, sensitive, and precise high performance liquid 
chromatographic (HPLC) method for the analysis of Paracetamol with ultraviolet detection at 257 nm has 
been developed, validated, and used for the determination of compounds in commercial pharmaceutical 
products. Paracetamol tablet dosage form (two brands) was purchased from market and was from Glaxo 
Smith Kline (Calpol) and from IPCA (Pacimol) respectively. The compounds were well separated on a 
Hypersil ODS C18 reversed-phase column by use of a mobile phase consisting of methanol and water 
(90:10v/v at a flow rate of 1.0 ml.min). The linearity ranges were 20- 100µg/ ml for Paracetamol. Limits of 
detection (LOD) obtained 3.298g/ml limit of quantitation (LOQ) were 9.875g/ml Paracetamol. The study 
showed that reversed-phase liquid chromatography is sensitive and selective for the determination of 
Paracetamol using single mobile phase. 
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INTRODUCTION 
Methods validation is the process of demonstrating the 
analytical procedures that are suitable for their intended 
use. The methods validation process for analytical 
procedures begins with the planned and systematic 
collection of the validation data to support the 
analytical procedures. The review chemist evaluates 
the analytical procedures and validation data. [1] 
Validation can be defined as a procedure that 
demonstrates a process under standard conditions 
capable of consistently producing a product that meets 
the established product specification. In pharmaceutical 
industry validation studies are an essential part of GMP 
as well as GLP and should be conducted in accordance 
with predefined protocols. [2] A written report 
summarizing recorded results and conclusions should 
be prepared and stored. There are guidelines given by 
ICH, USFDA and European Union (European Medical 
Evaluation Agency) for adhering the principles started 
for GMP and GLP requirements. [3, 4]  
 
 
Paracetamol is a pioneer antipyretic drug. Chemically 
it is N-(4-hydroxyphenyl) acetamide. The molecular 
formula of Paracetamol is C8H9NO2
. It is an acyclic 
drug, freely soluble in water, chloroform and ethanol. It 
is a white powder. The main mechanism of action of 
paracetamol is considered to be the inhibition of 
cyclooxygenase (COX), and recent findings suggest 
that it is highly selective for COX-2. While it has 
analgesic and antipyretic properties comparable to 
those of aspirin or other NSAIDs, its peripheral anti-
inflammatory activity is usually limited by several 
factors, one of which is high level of peroxides present 
in inflammatory lesions.[5]  
According to the literature survey, methods were 
developed using buffer solutions and biological fluids. 
Using of buffer solutions and biological fluids leads to 
various difficulties as, i) Only small quantity of drug or 
metabolite is usually present in large volume of blood, 
urine or tissues. ii) Endogenous pigments leads to 
analytical error, unless great care is taken in the 
analytical conditions. iii) Protein binding of the drugs 
may occur which may lead to poor recoveries. iv) 
Buffer solutions that are used should be freshly 
prepared.[6,7] v) Quantification of drug plasma levels 
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from patients is a quite complicated operation. At the 
patient individual level, these assays require a large 
volume of plasma sample. vi) TDM (Therapeutic Drug 
Monitoring) –Prospective clinical trials assessing the 
clinical usefulness of this strategy have shown 
contradictory results, pointing out the need to consider 
different issues when performing TDM. Whereas in 
case of methanol-water there is no need to prepare it 
freshly since % recovery is highly satisfactory. [8] The 
main objective in this research work is to develop a 
simple, rapid, reliable and an economical single 
method for Paracetamol by RP-HPLC in individual 
drugs and decrease the time and cost of the assays.  
 
MATERIAL AND METHODS 
HPLC instrument of LC-10AT VP series (Shimadzu 
Corporation, Japan) consisting of a UV-Visible 
detector, manual injector with 20µl loop and Hypersil 
ODS C18 column (250 mm X 4.6 mm i.d., 5µm 
particle sizes) was used. All the standards and 
chemicals used were of HPLC-grade. Methanol was 
obtained from S. d. Fine Chemicals Ltd. (Mumbai, 
India) and triple distilled water was received from 
Universal Labortories Pvt. Ltd. (Mumbai, India). 
Paracetamol tablets (Calpol, Glaxo Smith Kline. and 
Pacimol, IPCA) were purchased from market.  
Standard Solution Preparation (Stock and working 
standard solution): 
Stock and working standard solution for Paracetamol 
stock solution was prepared by weighing Paracetamol 
(100 mg) in a 100-ml volumetric flask, dissolving in 70 
ml methanol and diluting to volume with the methanol, 
10 ml was further diluted to 100 ml with mobile phase 
to obtain working standard solutions with Paracetamol. 
Then it was further diluting to 20µg/ml to 100µg/ml 
paracetamol solutions by using mobile phase as a 
solvent. [9] 
Preparation of the sample solutions (Stock and 
working standard solution):  
Twenty tablets (CALPOL and PACIMOL) were 
weighed accurately and finely powdered in a mortar 
and pastel. From the powder equivalent weight of 100 
mg was taken in 100 ml volumetric flask. This was 
dissolved in 70 ml water and sonicated for 30 min with 
internal shaking. Then the volume was finally made to 
100ml with methanol to get a clear solution of 1mg/ml. 
The above solution was centrifuged at 3000 rpm for 5 
min. 10 ml was further diluted to 100 ml with mobile 
phase to obtain working standard solutions with 
Paracetamol. Further it was diluted to 20µg/ml to 
100µg/ml solutions by using mobile phase as solvent[10] 
Chromatographic condition 
Chromatography was performed on Hypersil C18 
reversed phase column (250 mm x 4.6 mm i.d., 5µl) 
base deactivated silyl bonded amorphous silica. The 
mobile phase was methanol and water, 90:10 (v/v). 
Flow-rate was maintained at 1ml/min. The column was 
kept at 25.0 ± 0.10C during the analysis. The detection 
wavelength was set at 257 nm and the injection volume 
at 20µl.  
 
RESULTS 
Method Validation 
To optimize the HPLC parameters, several mobile 
phase compositions were tried. A satisfactory   
separation and peak symmetry for Paracetamol was 
obtained with mobile phase consisting of methanol and 
water (90:10v/v) so as to obtain a better reproducibility 
and repeatability. Quantification was achieved with UV 
detection at 257nm based on the peak area. Better 
resolution of the peaks with clear base line separation 
was found (Fig. 1). Limits of detection (LOD) obtained 
a value of 3.298 g/ml and the limit of quantitation 
(LOQ) obtained a value of 9.875g/ml paracetamol. 
The study showed that reversed-phase liquid 
chromatography is sensitive and selective for the 
determination of Paracetamol using single mobile 
phase. [11] 
Specificity (Selectivity) 
The selectivity of the RP-HPLC method was checked 
by comparison of chromatograms obtained from 
samples and the corresponding placebo. Additives in 
tablets are practically insoluble in methanol or the 
mobile phase whereas the active constituents are freely 
Journal of Applied Pharmaceutical Research ISSN No. 2348 – 0335 www.japtronline.com 
 
 
 
October – December 2013 Volume 1                                        Issue 1 38 
 
soluble. Hence, no interference from additives of the 
tablets was obtained. 
Linearity 
The linearity of the method was determined by analysis 
of standard plots associated with six point standard 
calibration curve. The concentration was calculated 
from the simple linear equation using regression 
analysis of calibration standard with the reciprocal of 
the drug concentration as a weighing factor. The peak 
area ratio values of calibration standards were 
proportional to the drugs. The plot of peak area of each 
sample against respective concentration of Paracetamol 
was found to be linear in the range of 20-100μg/ml. 
Using regression analysis the linear equation was 
obtained Y= 43.45x - 3.101 with correlation coefficient 
of R2= 0.9999. Linear regression least square fit data 
obtained from the measurements are given in table. [12] 
The linearity of the method was determined by analysis 
of standard plots associated with a six -point standard 
calibration curve. 
Accuracy 
The recovery experiments were carried out by the 
standard addition method. The percentage of the 
recoveries obtained were 99.713% and 99.72% 
respectively for Paracetamol (Brand1 and Brand 2) and 
the results are shown in the table below. The recovery 
of the method was highly satisfactory.  
 
Fig I: Peak area and peak height Paracetamol 40µg  
 
Table I: Condition applied 
Concentration  Regression Equation R
2 
 
20-80 Y=43.44X +12.44 0.999 
20-80 Y=43.32X-6.190 0.999 
Fig II: Standard calibration curve of Paracetamol  
     
 
Table II: Paracetamol regression statistics 
Column Mode           : C18 RP-HPLC 
Detector                     : UV – Visible 
Type of Analysis         : Peak area and peak height 
Detection Limit           : 257 nm 
Flow Rate                    : 1.0 ml/min 
Run Time                    : 10 min 
Injection volume         : 20 µl 
 
Table III: Recovery studies  
Labeled claim 75mg Amount 
added (mg) 
% Recovery 
Brand 1 
(Calpol, Glaxo Smith 
Kline) 
10 
20 
30 
99.67 
100.04 
99.43 
Brand 2 
(Pacimol, IPCA) 
10 
20 
30 
99.85 
99.23 
100.08 
*Mean determination of five is 99.713 & 99.72 
 
Precision 
System precision  
The precision of an analytical method is the degree of 
agreement among the individual test results when the 
method is applied repeatedly to multiple sampling of a 
homogenous sample. The precision was calculated as 
the percentage coefficient of variation (% CV) or 
Relative standard deviation (% RSD). Repeatability 
refers to the use of the analytical procedure within a 
laboratory over a short period of time (Intra-day) using 
the same analytes with the same equipment. 
Repeatability was studied by injecting 3 concentrations 
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of standard drug three times during the same day. The 
method passed test for repeatability, as the % RSD 
≤2%. 
 
Table IV: Intraday precision of Paracetamol by the 
proposed RP- HPLC method 
Concentration 
Paracetamol 
(g/ml) 
Mean 
area  
(n= 3) 
Standard 
deviation 
%RSD 
(n= 3) 
20 865.004 12.265 1.417 
40 1799.36 24.457 1.359 
80 3467.13 47.031 1.356 
 
Intermediate precision  
Involve in the estimation of variations in analysis when 
method is used within a laboratory, as on different days 
(Inter-day).  Intermediate precision was studied by 
injecting 3 concentration of standard in triplicates on 3 
different days. The method was passed the test for 
intermediate precision, as the % RSD ≤1.5%. 
 
Ruggedness 
A different analyst, using a different batch of 
chemicals, tried the method graph. There was not much 
variation in results. These studies showed that the 
method is rugged. 
 
Table V: Inter- Day precision of Paracetamol by the 
proposed RP- HPLC Method 
Concentration 
Paracetamol 
(g/ml) 
Mean area 
(n= 9) 
Standard 
deviation 
%RSD 
(n= 9) 
20 864.371 11.093 1.283 
40 1708.29 21.991 1.287 
80 3467.99 43.302 1.248 
 
Robustness 
Robustness of the method was tested by small but 
deliberate variations of flow rate mobile phase and 
temperature. Effects of variation in the flow rate (±1 
ml/min) were studied at three different concentrations 
and temperatures (±1˚C to ±5˚C). Effect of variation in 
the different mobile phase ratio was also studied at 
three different concentrations. The results are given in 
the following table. 
 
  Fig III: Interday graph of Paracetamol 
          
 
Fig IV: Intraday- graph of Paracetamol 
 
   
Fig V: Analyst-1 Paracetamol                                    
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Fig. VI: Analyst -2 Paracetamol 
 
Table V: Analyst-1 for Paracetamol 
Concentration Peak area 
(mV.s)* 
SD %RSD* 
20 883.659 10.006 1.132 
40 1708.514 19.512 1.142 
80 3417.634 29.182 0.853 
*Average of three values 
 
System suitability test 
The percentage of relative standard deviation (% RSD) 
for Paracetamol was found to be 1.144, using this 
method. All the results were within the acceptable 
range. System suitability tests are an integral part of 
chromatographic methods and are used to verify that 
the resolution and reproducibility of the system are 
adequate for analysis to be performed. All the values 
for system suitability parameters were within 
acceptable range. [13] 
 
Table VI: Analyst-2 for Paracetamol 
Concentration Peak area 
(mV.s)* 
SD %RSD* 
20 864.563 9.895 1.144 
40 1743.614 17.574 1.007 
80 3419.619 32.938 0.963 
*Average of three values 
 
Table II describes Paracetamol regression statistics for 
intraday and interday. The linearity of the method was 
observed in the concentration range of 50-200µg/ml, 
with a regression coefficient of 0.9999, demonstrating 
its suitability for analysis. 
Table VII: Effect of variations in the flow rate of 
(1.0 ml/min) for Paracetamol 
Concentr
ation 
Retention 
Time* 
Peak area 
(mV.s)* 
SD %RSD 
20 2.897 864.465  10.01 1.158 
40 2.898 1729.17 17.98 1.039 
80 2.900 3457.60 24.87 0.719 
*Average of three values 
 
Table VIII: System suitability test for Paracetamol 
Regression analysis 
Parameters Values 
Retention Time 2.898 
HETP(mm) 0.009 
Tailing factor 1.011 
Theoretical plates/m 110103.84 
LOD(g/ml) 3.298 
LOQ(g/ml) 9.875 
 
DISCUSSION 
Apropos of the above, liquid chromatographic method 
was described and the results were given. According to 
the result, limits of detection (LOD) was obtained 
3.298g/ml, limit of quantitation (LOQ) was 
9.875g/ml and % recovery was 99.713% and 99.72% 
for CALPOL and PACIMOL respectively, with a 
regression coefficient of 0.9999 (Intraday &Interday). 
So the method was proven to be validated. From the 
standard calibration curve the regression coefficient (r2) 
value was found 0.999 by using the concentration of 
20-100µg/ml (Y=43.44X +12.44, Y=43.32X-6.190).  
 
CONCLUSION 
Developed high performance liquid chromatographic 
method is simple, reliable, reproducible and 
economical for the analysis of paracetamol in 
pharmaceutical formulations. The reported method can 
be used successfully for the effective qualitative and 
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quantitative analysis of Paracetamol in tablets or other 
pharmaceutical formulations.  Limits of detection 
(LOD) obtained was 3.298g/ml, limit of quantitation 
(LOQ) was 9.875g/ml. 
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